666

ADVAGENE BIOPHARMA CO LTD

No trades
See on Supercharts

6709 fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

Advagene Biopharma Co., Ltd. engages in the development of products such as nasal influenza vaccine, airway allergy immunotherapy and COVID-19 immunotherapy. The company was founded on September 19, 2006 and is headquartered in Taipei, Taiwan.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

6709 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company